Recently, Doubrovina et al., have established that MICA in serum from patients with colon adenocarcinoma down-modulates NKG2D expression on NK cells via its internalization and subsequent lysosomal degradation [35]. The gene discussed is KLRK1; the disease is colon adenocarcinoma.